SkinIO, a healthcare technology company that offers skin cancer screening and tracking, has raised $1.4 million USD through a private offering of securities.
Syapse, a leading real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, today announced the closing of a $68 million growth equity investment to expand Syapse's focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer. The investment is led by Ally Bridge Group (ABG), with Northpond Ventures and existing investors also participating in the financing. Andrea Jackson, Director for Northpond Ventures, will be joining the Syapse Board of Directors.
Blue Note Therapeutics, a clinical-stage biotechnology company focused on developing non-invasive treatments for neurological and psychiatric disorders, has raised $15.5 million USD through a private offering of securities.
The Berlin-based health start-up Fosanis, provider of the Mika app, has successfully closed another round of funding. Investors are Ananda Impact Ventures, Evodia and IBB Ventures. Fosanis will use the raised capital to further develop its product and to accelerate the distribution of the Mika app. In addition, Fosanis will advance the scientific studies on the effectiveness of Mika.
Blackford Analysis, a healthcare technology company that offers clinical imaging solutions, has raised $687K through a private offering of securities, according to the SEC form registered.
Comprehensive digital oncology platform, Karkinos Healthcare closed a funding round with the Tatas Group drawing an investment of Rs. 110 crores. Tata Group has disbursed Rs. 35 crores immediately and the rest of the funding is expected to be disbursed by the Group in tranches in the coming months. Investment in Karkinos Healthcare has proved that the Tatas has been aggressively pursuing their interest in healthcare with green field and brown field ventures.
Insilico Medicine is a research and development company of anti-aging and cancer treatment drugs. Relying on genomics, medical big data and AI technology and other technical means, it focuses on the research and development, production and sales of cancer treatment and anti-aging drugs. At the same time, it provides users with health management, Cancer prevention and other services. Recently completed strategic financing, the investor is Fosun Pharma.
Today, British pharmaceuticals giant AstraZeneca announced it has invested $33 million (about �25 million) in the company as part of a broader commercial tie-up between the two firms, according to a report from CNBC citing a person familiar with the matter. The deal marks a rare start-up investment for AstraZeneca.
Karkinos Healthcare, a technology-driven oncology focussed healthcare platform on Sunday said that US-based Mayo Clinic has invested for a minority stake in the company The company didn't disclose the size of the investment. Karkinos said it will deploy the funds for development of innovative healthcare solutions. Mayo Clinic will also nominate a member on the Board of Karkinos as part of this agreement.
MedTech Innovator, the world's largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization's flagship four-month Accelerator program, featuring medical device, diagnostic, and digital health technologies from around the globe. As 2022 Cohort members, these startups will get unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders. At the conclusion of the program, MedTech Innovator will award $500,000 in cash and in-kind prizes in the final competition held at The MedTech Conference, powered by AdvaMed in Boston this fall.